Concepedia
Statistics
Publications
6
Citations
4K
H-Index
Active since
2006
Affiliations
Semmelweis University(Current)
Universidad de La Frontera
University of Latvia
Estudios Clínicos Latinoamérica
Population Health Research Institute
Hasan Alawi is an author at Semmelweis University specializing in diabetology, diabetes mellitus, and medicine.
Publications per year
2006–2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text
Medicine, Endocrinology, Pharmacology +14
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text
Medicine, Endocrinology, Nephrology +15
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations
Medicine, Pharmacology, Pharmacotherapy +15
Addressing Schemes of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A European Perspective and Expert Recommendation
Oliver Schnell, Hasan Alawi, Tadej Battelino et al. · Diabetes Technology & Therapeutics · 2011 · 47 citations
Medicine, Cardiology, Internal Medicine +17
Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial
Graydon S. Meneilly, Christine Roy-Duval, Hasan Alawi et al. · Diabetes Care · 2017 · 38 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 6